The FCC's Public Safety and Homeland Security Bureau has released a Public Notice announcing that the Emergency Alert System (EAS) Test ...

The ENLIGHTEN 2 trial also met the key secondary endpoints of 3CS at 24 weeks in the full population (i.e., patients with and without nasal polyps) (-0.90; p=0.0209) and in the clinically-validated ...